Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 448

1.

Direct Delivery of Kidney Transplant Education to Black and Low-Income Patients Receiving Dialysis: A Randomized Controlled Trial.

Waterman AD, Peipert JD, McSorley AM, Goalby CJ, Beaumont JL, Peace L.

Am J Kidney Dis. 2019 Jun 18. pii: S0272-6386(19)30733-4. doi: 10.1053/j.ajkd.2019.03.430. [Epub ahead of print]

PMID:
31227225
2.

Assessment of change in quality of life, carcinoid syndrome symptoms and healthcare resource utilization in patients with carcinoid syndrome.

Halperin DM, Huynh L, Beaumont JL, Cai B, Bhak RH, Narkhede S, Totev T, Duh MS, Neary MP, Cella D.

BMC Cancer. 2019 Mar 28;19(1):274. doi: 10.1186/s12885-019-5459-x.

3.

Palliative Care Usage in Young Adult Oncology Population.

Foster KD, Chuzi S, Beaumont JL, Kircher S, Smith M, Sanford S, Mohindra N.

J Palliat Med. 2019 Mar 22. doi: 10.1089/jpm.2018.0506. [Epub ahead of print]

PMID:
30907695
4.

A survey comparison of educational interventions for teaching pneumatic otoscopy to medical students.

Higgins Joyce A, Raman M, Beaumont JL, Heiman H, Adler M, Schmidt SM.

BMC Med Educ. 2019 Mar 12;19(1):79. doi: 10.1186/s12909-019-1507-0.

5.

A randomized controlled trial of Explore Transplant at Home to improve transplant knowledge and decision-making for CKD 3-5 patients at Kaiser Permanente Southern California.

Waterman AD, Anderson C, Alem A, Peipert JD, Beaumont JL, Henry SL, Dub B, Ambriz L, Bijjala N, Lipsey AF, Mittman B.

BMC Nephrol. 2019 Mar 4;20(1):78. doi: 10.1186/s12882-019-1262-9.

6.

Meaningful differences and validity for the NCCN/FACT-P Symptom Index: An analysis of the ALSYMPCA data.

Beaumont JL, Butt Z, Li R, Cella D.

Cancer. 2019 Jun 1;125(11):1877-1885. doi: 10.1002/cncr.31973. Epub 2019 Jan 28.

PMID:
30690719
7.

Relationship Between Symptoms and Health-related Quality-of-life Benefits in Patients With Carcinoid Syndrome: Post Hoc Analyses From TELESTAR.

Cella D, Beaumont JL, Hudgens S, Marteau F, Feuilly M, Houchard A, Lapuerta P, Ramage J, Pavel M, Hörsch D, Kulke MH.

Clin Ther. 2018 Dec;40(12):2006-2020.e2. doi: 10.1016/j.clinthera.2018.10.008. Epub 2018 Nov 24.

8.

Impact of carcinoid syndrome symptoms and long-term use of somatostatin analogs on quality of life in patients with carcinoid syndrome: A survey study.

Halperin DM, Huynh L, Beaumont JL, Cai B, Totev T, Bhak RH, Duh MS, Neary MP, Cella D.

Medicine (Baltimore). 2018 Nov;97(47):e13390. doi: 10.1097/MD.0000000000013390.

9.

Using the Patient-Reported Outcomes Measurement Information System (PROMIS) to measure symptom burden reported by patients with brain tumors.

Lai JS, Kupst MJ, Beaumont JL, Manley PE, Chang JH, Hartsell WF, Kwok Y, Fisher AP, Goldman S.

Pediatr Blood Cancer. 2019 Mar;66(3):e27526. doi: 10.1002/pbc.27526. Epub 2018 Nov 14.

PMID:
30426667
10.

Geographic and Provider Variations in Ocular Hypotensive Medication Claims Among Medicare Part D Enrollees.

Janetos TM, French DD, Beaumont JL, Tanna AP.

J Glaucoma. 2019 Feb;28(2):e29-e33. doi: 10.1097/IJG.0000000000001114.

PMID:
30358645
11.

Donor milk intake and infant growth in a South African neonatal unit: a cohort study.

Sparks H, Linley L, Beaumont JL, Robinson DT.

Int Breastfeed J. 2018 Sep 4;13:41. doi: 10.1186/s13006-018-0183-8. eCollection 2018.

12.

Measurement Characteristics of the Knowledge Assessment of Renal Transplantation.

Peipert JD, Hays RD, Kawakita S, Beaumont JL, Waterman AD.

Transplantation. 2019 Mar;103(3):565-572. doi: 10.1097/TP.0000000000002349.

PMID:
29965952
13.

Cold therapy to prevent paclitaxel-induced peripheral neuropathy.

Griffiths C, Kwon N, Beaumont JL, Paice JA.

Support Care Cancer. 2018 Oct;26(10):3461-3469. doi: 10.1007/s00520-018-4199-9. Epub 2018 Apr 21.

PMID:
29681015
14.

Fever Burden and Health-Related Quality of Life After Intracerebral Hemorrhage.

Bush RA, Beaumont JL, Liotta EM, Maas MB, Naidech AM.

Neurocrit Care. 2018 Oct;29(2):189-194. doi: 10.1007/s12028-018-0523-y.

PMID:
29600341
15.

What Else Can We Do to Ensure Transplant Equity for High-Risk Patients?

Waterman AD, Beaumont JL.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):529-530. doi: 10.2215/CJN.02120218. Epub 2018 Mar 26. No abstract available.

16.

Validity and usefulness of a single-item measure of patient-reported bother from side effects of cancer therapy.

Pearman TP, Beaumont JL, Mroczek D, O'Connor M, Cella D.

Cancer. 2018 Mar 1;124(5):991-997. doi: 10.1002/cncr.31133. Epub 2017 Nov 13.

17.

Computerized Adaptive Testing in Pediatric Brain Tumor Clinics.

Lai JS, Beaumont JL, Nowinski CJ, Cella D, Hartsell WF, Han-Chih Chang J, Manley PE, Goldman S.

J Pain Symptom Manage. 2017 Sep;54(3):289-297. doi: 10.1016/j.jpainsymman.2017.05.008. Epub 2017 Aug 8.

18.

Standardizing and personalizing the treat to target (T2T) approach for rheumatoid arthritis using the Patient-Reported Outcomes Measurement Information System (PROMIS): baseline findings on patient-centered treatment priorities.

Bacalao EJ, Greene GJ, Beaumont JL, Eisenstein A, Muftic A, Mandelin AM, Cella D, Ruderman EM.

Clin Rheumatol. 2017 Aug;36(8):1729-1736. doi: 10.1007/s10067-017-3731-5. Epub 2017 Jun 26.

PMID:
28653263
19.

Performance of Hispanics and Non-Hispanic Whites on the NIH Toolbox Cognition Battery: the roles of ethnicity and language backgrounds.

Flores I, Casaletto KB, Marquine MJ, Umlauf A, Moore DJ, Mungas D, Gershon RC, Beaumont JL, Heaton RK.

Clin Neuropsychol. 2017 May;31(4):783-797. doi: 10.1080/13854046.2016.1276216. Epub 2017 Jan 12.

20.

Clinical research participation among adolescent and young adults at an NCI-designated Comprehensive Cancer Center and affiliated pediatric hospital.

Sanford SD, Beaumont JL, Snyder MA, Reichek J, Salsman JM.

Support Care Cancer. 2017 May;25(5):1579-1586. doi: 10.1007/s00520-016-3558-7. Epub 2017 Jan 10.

21.

Utility of the Hemangioma Severity Scale as a Triage Tool and Predictor of Need for Treatment.

Mull JL, Chamlin SL, Lai JS, Beaumont JL, Cella D, Rancour EA, Baselga E, Haggstrom AN.

Pediatr Dermatol. 2017 Jan;34(1):78-83. doi: 10.1111/pde.13032. Epub 2016 Dec 16.

PMID:
27981617
22.

An evaluation of health-related quality of life in patients with systemic lupus erythematosus using PROMIS and Neuro-QoL.

Lai JS, Beaumont JL, Jensen SE, Kaiser K, Van Brunt DL, Kao AH, Chen SY.

Clin Rheumatol. 2017 Mar;36(3):555-562. doi: 10.1007/s10067-016-3476-6. Epub 2016 Nov 15.

PMID:
27848056
23.

Arterio-venous fistula for automated red blood cells exchange in patients with sickle cell disease: Complications and outcomes.

Delville M, Manceau S, Ait Abdallah N, Stolba J, Awad S, Damy T, Gellen B, Sabbah L, Debbache K, Audard V, Beaumont JL, Arnaud C, Chantalat-Auger C, Driss F, Lefrère F, Cavazzana M, Franco G, Galacteros F, Ribeil JA, Gellen-Dautremer J.

Am J Hematol. 2017 Feb;92(2):136-140. doi: 10.1002/ajh.24600. Epub 2016 Dec 7.

24.

Agitation, Delirium, and Cognitive Outcomes in Intracerebral Hemorrhage.

Rosenthal LJ, Francis BA, Beaumont JL, Cella D, Berman MD, Maas MB, Liotta EM, Askew R, Naidech AM.

Psychosomatics. 2017 Jan - Feb;58(1):19-27. doi: 10.1016/j.psym.2016.07.004. Epub 2016 Aug 5.

25.

Reduction of methicillin-resistant Staphylococcus aureus infection in long-term care is possible while maintaining patient socialization: A prospective randomized clinical trial.

Peterson LR, Boehm S, Beaumont JL, Patel PA, Schora DM, Peterson KE, Burdsall D, Hines C, Fausone M, Robicsek A, Smith BA.

Am J Infect Control. 2016 Dec 1;44(12):1622-1627. doi: 10.1016/j.ajic.2016.04.251. Epub 2016 Aug 1.

26.

Acupuncture-Related Quality of Life Changes Using PROMIS Computer Adaptive Tests in a Pragmatic Trial with Oncology and General Integrative Medicine Patients: The Role of Baseline Acupuncture Expectations.

Victorson D, Beaumont JL, Mahadevan R, Grimone A, Burns V, Murry W, Gutierrez S, Schuette S, Brady C, Ring M.

J Altern Complement Med. 2016 Oct;22(10):778-787. Epub 2016 Jul 28.

PMID:
27467506
27.

Safety and QOL in Patients with Advanced NET in a Phase 3b Expanded Access Study of Everolimus.

Pavel M, Unger N, Borbath I, Ricci S, Hwang TL, Brechenmacher T, Park J, Herbst F, Beaumont JL, Bechter O.

Target Oncol. 2016 Oct;11(5):667-675.

PMID:
27193465
28.

Health-related quality of life in patients with neuroendocrine tumors: an investigation of treatment type, disease status, and symptom burden.

Pearman TP, Beaumont JL, Cella D, Neary MP, Yao J.

Support Care Cancer. 2016 Sep;24(9):3695-703. doi: 10.1007/s00520-016-3189-z. Epub 2016 Mar 31.

PMID:
27029477
29.

Quality-adjusted time without symptoms or toxicity analysis of pazopanib versus sunitinib in patients with renal cell carcinoma.

Beaumont JL, Salsman JM, Diaz J, Deen KC, McCann L, Powles T, Hackshaw MD, Motzer RJ, Cella D.

Cancer. 2016 Apr 1;122(7):1108-15. doi: 10.1002/cncr.29888. Epub 2016 Jan 27.

30.

Validity of PROMIS physical function measured in diverse clinical samples.

Schalet BD, Hays RD, Jensen SE, Beaumont JL, Fries JF, Cella D.

J Clin Epidemiol. 2016 May;73:112-8. doi: 10.1016/j.jclinepi.2015.08.039. Epub 2016 Mar 9.

31.

Documentation of Fertility Preservation Discussions for Young Adults With Cancer: Examining Compliance With Treatment Guidelines.

Salsman JM, Yanez B, Smith KN, Beaumont JL, Snyder MA, Barnes K, Clayman ML.

J Natl Compr Canc Netw. 2016 Mar;14(3):301-9.

32.

PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions.

Cook KF, Jensen SE, Schalet BD, Beaumont JL, Amtmann D, Czajkowski S, Dewalt DA, Fries JF, Pilkonis PA, Reeve BB, Stone AA, Weinfurt KP, Cella D.

J Clin Epidemiol. 2016 May;73:89-102. doi: 10.1016/j.jclinepi.2015.08.038. Epub 2016 Mar 4.

33.

The PROMIS satisfaction with social participation measures demonstrated responsiveness in diverse clinical populations.

Hahn EA, Beaumont JL, Pilkonis PA, Garcia SF, Magasi S, DeWalt DA, Cella D.

J Clin Epidemiol. 2016 May;73:135-41. doi: 10.1016/j.jclinepi.2015.08.034. Epub 2016 Feb 27.

34.

Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis.

Yount SE, Beaumont JL, Chen SY, Kaiser K, Wortman K, Van Brunt DL, Swigris J, Cella D.

Lung. 2016 Apr;194(2):227-34. doi: 10.1007/s00408-016-9850-y. Epub 2016 Feb 9.

PMID:
26861885
35.

Pazopanib in the treatment of advanced renal cell carcinoma.

Cella D, Beaumont JL.

Ther Adv Urol. 2016 Feb;8(1):61-9. doi: 10.1177/1756287215614236. Review. Erratum in: Ther Adv Urol. 2016 Aug;8(4):291.

36.

Demographically Corrected Normative Standards for the Spanish Language Version of the NIH Toolbox Cognition Battery.

Casaletto KB, Umlauf A, Marquine M, Beaumont JL, Mungas D, Gershon R, Slotkin J, Akshoomoff N, Heaton RK.

J Int Neuropsychol Soc. 2016 Mar;22(3):364-74. doi: 10.1017/S135561771500137X. Epub 2016 Jan 28.

37.

Nonimpact of Decolonization as an Adjunctive Measure to Contact Precautions for the Control of Methicillin-Resistant Staphylococcus aureus Transmission in Acute Care.

Peterson LR, Wright MO, Beaumont JL, Komutanon V, Patel PA, Schora DM, Schmitt BH, Robicsek A.

Antimicrob Agents Chemother. 2015 Oct 12;60(1):99-104. doi: 10.1128/AAC.02046-15. Print 2016 Jan.

38.
39.

The NIH Toolbox Pattern Comparison Processing Speed Test: Normative Data.

Carlozzi NE, Beaumont JL, Tulsky DS, Gershon RC.

Arch Clin Neuropsychol. 2015 Aug;30(5):359-68. doi: 10.1093/arclin/acv031. Epub 2015 May 29.

40.

Dichotomous "Good Outcome" Indicates Mobility More Than Cognitive or Social Quality of Life.

Naidech AM, Beaumont JL, Berman M, Francis B, Liotta E, Maas MB, Prabhakaran S, Holl J, Cella D.

Crit Care Med. 2015 Aug;43(8):1654-9. doi: 10.1097/CCM.0000000000001082.

41.

A patient-centered symptom monitoring and reporting system for children and young adults with cancer (SyMon-SAYS).

Lai JS, Yount S, Beaumont JL, Cella D, Toia J, Goldman S.

Pediatr Blood Cancer. 2015 Oct;62(10):1813-8. doi: 10.1002/pbc.25550. Epub 2015 Apr 9.

PMID:
25856587
42.

EORTC QLQ-BR23 and FACT-B for the assessment of quality of life in patients with breast cancer: a literature review.

Nguyen J, Popovic M, Chow E, Cella D, Beaumont JL, Chu D, DiGiovanni J, Lam H, Pulenzas N, Bottomley A.

J Comp Eff Res. 2015 Mar;4(2):157-66. doi: 10.2217/cer.14.76. Review.

PMID:
25825844
43.

Validation of an Alzheimer's disease assessment battery in Asian participants with mild to moderate Alzheimer's disease.

Shen JH, Shen Q, Yu H, Lai JS, Beaumont JL, Zhang Z, Wang H, Kim SY, Chen C, Kwok T, Wang SJ, Lee DY, Harrison J, Cummings J.

Am J Neurodegener Dis. 2014 Dec 5;3(3):158-69. eCollection 2014.

44.

Development and validation of the functional assessment of cancer therapy-antiangiogenesis subscale.

Kaiser K, Beaumont JL, Webster K, Yount SE, Wagner LI, Kuzel TM, Cella D.

Cancer Med. 2015 May;4(5):690-8. doi: 10.1002/cam4.385. Epub 2015 Jan 26.

45.

Development and Validation of a Quality-of-Life Instrument for Infantile Hemangiomas.

Chamlin SL, Mancini AJ, Lai JS, Beaumont JL, Cella D, Adams D, Drolet B, Baselga E, Frieden IJ, Garzon M, Holland K, Horii KA, Lucky AW, McCuaig C, Metry D, Morel KD, Newell BD, Nopper AJ, Powell J, Siegel D, Haggstrom AN.

J Invest Dermatol. 2015 Jun;135(6):1533-1539. doi: 10.1038/jid.2015.18. Epub 2015 Jan 23.

46.

Validation and important differences for the Sarcoidosis Assessment Tool. A new patient-reported outcome measure.

Judson MA, Mack M, Beaumont JL, Watt R, Barnathan ES, Victorson DE.

Am J Respir Crit Care Med. 2015 Apr 1;191(7):786-95. doi: 10.1164/rccm.201410-1785OC.

PMID:
25594886
47.

Web-Based Assessment of Outcomes After Subarachnoid and Intracerebral Hemorrhage: A New Patient Centered Option for Outcomes Assessment.

Naidech AM, Beaumont JL, Berman M, Liotta E, Maas MB, Prabhakaran S, Kording K, Holl J, Cella D.

Neurocrit Care. 2015 Aug;23(1):22-7. doi: 10.1007/s12028-014-0098-1.

PMID:
25510897
48.

Normative Scores for the NIH Toolbox Dynamic Visual Acuity Test from 3 to 85 Years.

Li C, Beaumont JL, Rine RM, Slotkin J, Schubert MC.

Front Neurol. 2014 Oct 30;5:223. doi: 10.3389/fneur.2014.00223. eCollection 2014.

49.

Longitudinal evaluation of PROMIS-29 and FACIT-dyspnea short forms in systemic sclerosis.

Hinchcliff ME, Beaumont JL, Carns MA, Podlusky S, Thavarajah K, Varga J, Cella D, Chang RW.

J Rheumatol. 2015 Jan;42(1):64-72. doi: 10.3899/jrheum.140143. Epub 2014 Nov 1.

50.

Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia.

Salsman JM, Beaumont JL, Wortman K, Yan Y, Friend J, Cella D.

Support Care Cancer. 2015 May;23(5):1355-64. doi: 10.1007/s00520-014-2484-9. Epub 2014 Oct 29.

Supplemental Content

Loading ...
Support Center